These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1334136)

  • 1. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
    Valk PE; Mathis CA; Prados MD; Gilbert JC; Budinger TF
    J Nucl Med; 1992 Dec; 33(12):2133-7. PubMed ID: 1334136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
    Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
    J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO).
    Tochon-Danguy HJ; Sachinidis JI; Chan F; Chan JG; Hall C; Cher L; Stylli S; Hill J; Kaye A; Scott AM
    Nucl Med Biol; 2002 Feb; 29(2):191-7. PubMed ID: 11823124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
    Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
    J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
    Cher LM; Murone C; Lawrentschuk N; Ramdave S; Papenfuss A; Hannah A; O'Keefe GJ; Sachinidis JI; Berlangieri SU; Fabinyi G; Scott AM
    J Nucl Med; 2006 Mar; 47(3):410-8. PubMed ID: 16513609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas.
    Yamamoto Y; Maeda Y; Kawai N; Kudomi N; Aga F; Ono Y; Nishiyama Y
    Nucl Med Commun; 2012 Jun; 33(6):621-5. PubMed ID: 22422099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
    Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia.
    Piert M; Machulla H; Becker G; Stahlschmidt A; Patt M; Aldinger P; Dissmann PD; Fischer H; Bares R; Becker HD; Lauchart W
    Eur J Nucl Med; 1999 Feb; 26(2):95-109. PubMed ID: 9933343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.
    Imahori Y; Ueda S; Ohmori Y; Kusuki T; Ono K; Fujii R; Ido T
    J Nucl Med; 1998 Feb; 39(2):325-33. PubMed ID: 9476945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.
    Spence AM; Muzi M; Swanson KR; O'Sullivan F; Rockhill JK; Rajendran JG; Adamsen TC; Link JM; Swanson PE; Yagle KJ; Rostomily RC; Silbergeld DL; Krohn KA
    Clin Cancer Res; 2008 May; 14(9):2623-30. PubMed ID: 18451225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
    Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
    No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma.
    Yeh SH; Liu RS; Wu LC; Yang DJ; Yen SH; Chang CW; Yu TW; Chou KL; Chen KY
    Eur J Nucl Med; 1996 Oct; 23(10):1378-83. PubMed ID: 8781144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO).
    Yuan H; Frank JE; Merrill JR; Hillesheim DA; Khachaturian MH; Anzellotti AI
    Curr Radiopharm; 2016; 9(3):235-243. PubMed ID: 27562785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.
    Szeto MD; Chakraborty G; Hadley J; Rockne R; Muzi M; Alvord EC; Krohn KA; Spence AM; Swanson KR
    Cancer Res; 2009 May; 69(10):4502-9. PubMed ID: 19366800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of hypoxic tissue on 18F-fluoromisonidazole PET after intracerebral hemorrhage.
    Hirano T; Read SJ; Abbott DF; Sachinidis JI; Tochon-Danguy HJ; Egan GF; Bladin CF; Scott AM; McKay WJ; Donnan GA
    Neurology; 1999 Dec; 53(9):2179-82. PubMed ID: 10599802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole.
    Read SJ; Hirano T; Abbott DF; Sachinidis JI; Tochon-Danguy HJ; Chan JG; Egan GF; Scott AM; Bladin CF; McKay WJ; Donnan GA
    Neurology; 1998 Dec; 51(6):1617-21. PubMed ID: 9855512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of survival in glioma patients by means of positron emission tomography.
    Patronas NJ; Di Chiro G; Kufta C; Bairamian D; Kornblith PL; Simon R; Larson SM
    J Neurosurg; 1985 Jun; 62(6):816-22. PubMed ID: 2987440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.
    Gu S; Chakraborty G; Champley K; Alessio AM; Claridge J; Rockne R; Muzi M; Krohn KA; Spence AM; Alvord EC; Anderson AR; Kinahan PE; Swanson KR
    Math Med Biol; 2012 Mar; 29(1):31-48. PubMed ID: 21562060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain tumor imaging with synthesized 18F-fluorophenylalanine and positron emission tomography.
    Mineura K; Kowada M; Shishido F
    Surg Neurol; 1989 Jun; 31(6):468-9. PubMed ID: 2718089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.